26 Feb 2017 | 8:17 AM
 

Glenmark Pharmaceuticals Ltd. Share Price Live (BSE)
0

BSE Code: 532296 | NSE Symbol: GLENMARK
933.05
-11.45
(-1.21 %)
23 Feb 2017 | 04:01 PM
Change company
  • Open (Rs)
    938.90
  • Prev. close (Rs.)
    944.50
  • High (Rs.)
    950.00
  • Low (Rs.)
    925.25
  • 52W H (Rs.)
    993.00
  • 52W L (Rs.)
    715.80
  • Volume (Rs.)
    16563
  • MCap (Rs in Cr.)
    26,327.69
937.25
-9.50
(-1.00 %)
  • Open (Rs)
    942.15
  • High (Rs)
    953.50
  • Low (Rs)
    931.15
  • Prev. close(Rs)
    946.75
  • Contracts Tra.
    11,38,900
  • Turnover (Cr.)
    108
  • Open Interest
    22,56,800
  • Open Int. chg
    6,48,900.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
24.88
Operating Margin (%)
18.56
Gross Profit Margin (%)
15.03
Net Profit Margin (%)
9.19
Total Debt/Equity
0.77
Dividend payout Ratio (Net Profit)
0.00
Earning Retention Ratio
100.00

News

03 Feb 2017 - 12:18:00-Shares of Glenmark Pharmaceuticals surged nearly 7 per cent on the Bombay Stock Exchange after the d...
03 Feb 2017 - 12:08:00-Pharma major Glenmark Pharmaceuticals Ltd posted smart Q3 numbers by reporting a jump of over two-fo...
27 Dec 2016 - 09:57:00-Glenmark Pharmaceuticals Inc...
13 Dec 2016 - 09:28:00-Leading pharma major Glenmark Pharmaceuticals Inc...

Announcements

21-Feb-2017
Glenmark Pharma - Updates
02-Feb-2017
Glenmark Pharmaceuticals Ltd. - Clarification
30-Jan-2017
Glenmark Pharma - Details of Earnings Call
12-Jan-2017
Glenmark Pharma - Shareholding for the Period Ended December 31 2016
12-Jan-2017
Glenmark Pharma - Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended Decembe

Religare Research

23 Feb 2017 | 06:00 PM
This week, we haven’t initiated fresh position, keeping in mind overbought market conditions and num...
23 Feb 2017 | 06:00 PM
Nifty index settled on a positive note for the fifth successive week, hitting 52 week high on the la...
23 Feb 2017 | 12:45 PM
VIP Industries (VIP) reported in-line numbers for Q3FY17 with a revenue and PAT growth of 5.5% & 43....
23 Feb 2017 | 11:15 AM
Agri Fundamental report

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
10,00,000 115.06 73.10 -0.06
10,00,000 115.06 66.47 -0.06
10,00,000 115.06 187.27 -0.06
10,00,000 115.06 191.77 -0.06
10,00,000 115.06 75.36 -0.06

Shareholding Pattern

       
Promotors46.49%
Mutual Funds/UTI3.48%
FI/Banks3.38%
Insurance3.38%
FII34.38%
Government0.00%
Others3.87%

Peer Group

Company Intraday Graph
 Dr. Reddy`s Laboratories Ltd.
2,890.15(-0.31)
3294
 GlaxoSmithKline Pharmaceuticals Ltd.
2,660.10(-0.52)
3317
 Alkem Laboratories Ltd.
2,073.85(2.55)
17141
 Piramal Enterprises Ltd.
1,866.45(-1.66)
3356

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Glenmark Pharmaceuticals Ltd.56.9532.6584.50
NIFTY(S&P CNX)548.00906.20306.90
BSE SENSEX1,775.632,841.16902.76
BSE 500763.721,333.78587.62

Corporate Details

Key Personal
B E Saldanha
Non Executive Director
Bernard Munos
Non Executive Director
Brian W Tempest
Non Executive Director
Key Address
Registered Office
B/2 Mahalaxmi Chambers 22 Bhulabhai Desai Road,Mumbai,Maharashtra

Tel:022-40189999 40189879, Fax:022-40189986

complianceofcer@glenmarkpharma.com
http://www.glenmarkpharma.com
Registrar Office
Karvy Computershare Private Ltd.
Add. :Karvy Selenium Tower B Plot No. 31-32 Gachibowli Financial District Nanakramguda

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Glenmark Pharmaceuticals Ltd. that will help you decide whether to buy, sell or hold Glenmark Pharmaceuticals Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Glenmark Pharmaceuticals Ltd.